Journal of Autism and Developmental Disorders

, Volume 29, Issue 1, pp 87–91

Brief Report: Two-Year Control of Behavioral Symptoms with Risperidone in Two Profoundly Retarded Adults with Autism

  • Nancy A. Dartnall
  • Janice P. Holmes
  • Susan Naylor Morgan
  • Christopher J. McDougle
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclaire, L., & Arnott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia. Journal of Clinical Psychopharmacology, 13, 5–40.Google Scholar
  2. Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.Google Scholar
  3. Feeney, D. J., & Klykylo, W. (1996). Risperidone and tardive dyskinesia. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1421–1422.Google Scholar
  4. Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.Google Scholar
  5. Grant, S., & Fitton, A. (1994). Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs, 48, 253–273.Google Scholar
  6. Hardan, A., Johnson, K., Johnson, C., & Hrecznyj, B. (1996). Case study: Risperidone treatment of children and adolescents with developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1551–1556.Google Scholar
  7. Horrigan, J. P., & Barnhill, L. J. (1997). Risperidone and explosive aggressive autism. Journal of Autism and Developmental Disorders, 27, 313–323.Google Scholar
  8. Kumra, S., Herion, D., Jacobsen, L. K., Briguglia, C., & Grothe, D. (1997). Case study: Risperidone-induced hepatotoxicity in pediatric patients. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 701–705.Google Scholar
  9. Leysen, J. E., Janssen, P. M. F., Megens, A. A. H. P., & Schotte, A. (1994). Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism. receptor occupancy profile, and pharmacologic activity. Journal of Clinical Psychiatry, 55 (5, Suppl.), 5–12.Google Scholar
  10. McDougle, C. J., Brodkin, E. S., Yeung, P. P., Naylor, S. T., Cohen, D. J., & Price, L. H. (1995). Risperidone in adults with autism or pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 34, 273–282.Google Scholar
  11. McDougle, C. J., Holmes, J. P., Bronson, M. R., Anderson, G. M., Volkmar, F. R., Price, L. H., & Cohen, D. J. (1997). Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685–693.Google Scholar
  12. McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.Google Scholar
  13. Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400–405.Google Scholar
  14. Simon, E. W., Blubaugh, K. M., & Pippidis, M. (1996). Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Mental Retardation, 34, 359–366.Google Scholar
  15. Touchette, P. E., MacDonald, R. F., & Langer, S. N. (1985). A scatter-plot for identifying stimulus control of problem behavior. Journal of Applied Behavior Analysis, 18, 343–351.Google Scholar
  16. Vanden Borre, R., Buttiens, M., Thiry, P., Geutjens, J., Sieben, G., & Heylen, S. (1993). Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind, cross-over study. Acta Psychiatrica Scandinavia, 87, 167–171.Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Nancy A. Dartnall
    • 1
  • Janice P. Holmes
    • 2
  • Susan Naylor Morgan
    • 3
  • Christopher J. McDougle
    • 4
  1. 1.Connecticut Department of Mental Retardation, South Central RegionWallingford
  2. 2.Clinical Neuroscience Research Unit, Connecticut Mental Health CenterYale University School of MedicineNew Haven
  3. 3.Harvard University Health ServiceCambridge
  4. 4.Department of PsychiatryIndiana University School of MedicineIndianapolis

Personalised recommendations